iBio (IBIO) Total Liabilities (2016 - 2025)
Historic Total Liabilities for iBio (IBIO) over the last 16 years, with Q4 2025 value amounting to $7.8 million.
- iBio's Total Liabilities rose 39.73% to $7.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.8 million, marking a year-over-year increase of 39.73%. This contributed to the annual value of $8.3 million for FY2025, which is 1207.83% up from last year.
- According to the latest figures from Q4 2025, iBio's Total Liabilities is $7.8 million, which was up 39.73% from $8.1 million recorded in Q3 2025.
- iBio's 5-year Total Liabilities high stood at $43.2 million for Q3 2021, and its period low was $6.8 million during Q3 2024.
- For the 5-year period, iBio's Total Liabilities averaged around $23.9 million, with its median value being $25.6 million (2023).
- Its Total Liabilities has fluctuated over the past 5 years, first plummeted by 7236.09% in 2024, then surged by 2000.59% in 2025.
- iBio's Total Liabilities (Quarter) stood at $35.8 million in 2021, then dropped by 8.01% to $33.0 million in 2022, then fell by 24.72% to $24.8 million in 2023, then tumbled by 68.57% to $7.8 million in 2024, then rose by 0.4% to $7.8 million in 2025.
- Its Total Liabilities was $7.8 million in Q4 2025, compared to $8.1 million in Q3 2025 and $8.3 million in Q2 2025.